← All trials
NCT05756166
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 30, 2023
- Primary completion
- Dec 30, 2025
- Completion date
- Dec 30, 2025
- First posted
- Mar 6, 2023
- Last posted
- Oct 31, 2023
- Enrollment
- 12
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- State University of New York, BuffaloLead sponsor
- National Cancer Institute (NCI)Collaborator
- State University of New York, BuffaloOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.